Effect of Serelaxin Versus Standard of Care in Acute Heart Failure (AHF) Patients
Clinical trial NCT02064868 · TERMINATED
Trial details
- NCT number
- NCT02064868
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-31
- Primary completion
- 2017-03-26
- Enrollment
- 2666
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.